Outlook Therapeutics® to Present at the SVB Securities

Outlook Therapeutics® to Present at the SVB Securities

– Russ Trenary, President and Chief Executive Officer of Outlook Therapeutics to present on Tuesday, February 14th at 4:20 PM ET –......

Clearside Biomedical OASIS Data to be Presented at Multiple

Clearside Biomedical OASIS Data to be Presented at Multiple

ALPHARETTA, Ga, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of......

2022 Fourth Quarter Earnings Conference Call Tuesday,

2022 Fourth Quarter Earnings Conference Call Tuesday,

BETHLEHEM, Pa., Feb. 07, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering......

iTeos to Present at SVB Securities Global Biopharma

iTeos to Present at SVB Securities Global Biopharma

WATERTOWN, Mass. and GOSSELIES, Belgium, Feb. 07, 2023 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical......

CENTOGENE to Participate in Upcoming Conferences in

CENTOGENE to Participate in Upcoming Conferences in

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for......

Synaptics Strengthens Leadership Team with Addition of Lori

Synaptics Strengthens Leadership Team with Addition of Lori

SAN JOSE, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) announced that it strengthened its leadership team with the......

Hyperfine Swoop® Point-of-Care MRI System™ Takes the Stage

Hyperfine Swoop® Point-of-Care MRI System™ Takes the Stage

Research highlights the significance and clinical relevance of portable MRI technology......

Perella Weinberg Partners to Present at the Credit Suisse

Perella Weinberg Partners to Present at the Credit Suisse

NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Perella Weinberg Partners (“PWP”) (NASDAQ:PWP), a leading global independent advisory firm, today announced......

MacroGenics to Participate in Upcoming Investor

MacroGenics to Participate in Upcoming Investor

ROCKVILLE, MD, Feb. 06, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing......

Arvinas to Participate in Upcoming Investor Conferences

Arvinas to Participate in Upcoming Investor Conferences

NEW HAVEN, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs......

  • 1
  • ...
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • ...
  • 44
  • menu
    menu